Journal profile · Immunology
Inflammation
ISSN 0360-3997 · eISSN 1573-2576 · Springer US · UNITED STATES · Bimonthly · Founded 1975
Inflammation: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.34; hybrid open access; APC about USD 4,790; median 91 days to acceptance (106 articles, last 24 months); community-reported acceptance: about 50%; 177 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Inflammation is published by Springer US and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Immune Response and Inflammation, Neutrophil, Myeloperoxidase and Oxidative Mechanisms and Inflammasome and immune disorders, together about 28.1% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Inflammation publishes the latest international advances in experimental and translational research on the physiology, biochemistry, cell biology, and pharmacology of inflammation. Contributions include full-length scientific reports, and short definitive articles. The journal's coverage includes acute and chronic inflammation; mediators of inflammation; mechanisms of tissue injury and cytotoxicity; pharmacology of inflammation; and translational studies of inflammation and its modification.
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editor-in-chief Massimo GadinaPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 22, Italy 8, United Kingdom 6, Japan 3, India 3 (52 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Response and InflammationImmunology and Microbiology15.4%
- Neutrophil, Myeloperoxidase and Oxidative MechanismsImmunology and Microbiology6.5%
- Inflammasome and immune disordersBiochemistry, Genetics and Molecular Biology6.2%
- Immune cells in cancerImmunology and Microbiology5.9%
- Asthma and respiratory diseasesMedicine5.4%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience5%
- NF-κB Signaling PathwaysBiochemistry, Genetics and Molecular Biology4.5%
- Cell Adhesion Molecules ResearchMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 3 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.34LetPub ·
- Impact factor (publisher) 2025
- 5.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.9Publisher website ·
- CiteScore 2026-06
- 9.3LetPub ·
- SJR 2026-06
- 1.52LetPub ·
- SNIP 2026-06
- 1.28LetPub ·
- h-index
- 51LetPub ·
- h-index
- 108OpenAlex ·
- i10-index
- 3,325OpenAlex ·
- 2-year mean citedness
- 5.36OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 41.08%LetPub ·
Volume
- Articles per year
- 153LetPub ·
- Downloads per year (publisher) 2025
- 1,300,000Publisher website ·
Articles by year OpenAlex count · 4,914 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 235 | 231 | 167 |
| 2025 | 177 | 155 | 928 |
| 2024 | 270 | 173 | 2,562 |
| 2023 | 173 | 56 | 2,866 |
| 2022 | 177 | 62 | 4,050 |
| 2021 | 206 | 45 | 5,807 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
91 daysMedian, submission to acceptance · P25–P75 68 days – 127 days
- Acceptance to online
- median 25 days (106 articles)
- Submission to online
- median 130 days
- Sample
- 106 articles with submission and acceptance dates (455 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,790 / EUR 3,690 / GBP 2,990 | — | — | |
| Publisher website | USD 1,150 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Page charges
- USD 1,150
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers3, by deadline
Publisher websiteWhat to prepare5 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
- Not considered
- studies on the effects of plant extracts on inflammation
Article types accepted3
- editorialSingle-blind peer review This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review proce…Length not stated
- original articlesInflammation considers Original Articles and Reviews.Length not stated
- reviewsInflammation considers Original Articles and Reviews.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship Policy
Will not consider studies on the effects of plant extracts on inflammation Model summary
Authorship should incorporate and should be restricted to those who have contributed substantially to the work in one or more of the following categories: • Conceived of or designed study • Performed research • Analyzed data • Contributed new methods or models • Wrote the paper Page Charges The journal makes no page charges. Color can be used without charge for the electronic edition of the journa…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Inflammation, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Single-blind peer review
Single-blind peer review Model summary
This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review process for these articles is the same as the peer review process of the journal in general. Additionally, if a guest editor authors an article in their issue/collection, they will not handle the peer review process.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1975
- ISSN
- 0360-3997
- Electronic ISSN
- 1573-2576
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Inflammation
What CAS zone is Inflammation in?
In the 2025 upgraded edition of the CAS Journal Ranking, Inflammation is in Zone 2 of Medicine, and in Zone 3 of the minor category Cell Biology / Immunology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Inflammation?
The latest impact factor listed by LetPub is 5.34; CiteScore 9.3, h-index 108.
How long does peer review take at Inflammation?
Based on the dates recorded on 106 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 91 days (interquartile range 68–127 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Inflammation?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Inflammation based?
Of the 52 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (22), Italy (8) and United Kingdom (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Inflammation?
According to LetPub and DOAJ records, Inflammation is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Inflammation open access, and what is the APC?
Inflammation is a hybrid journal. For open-access publication: APC about USD 4,790.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .